Univercells

Gosselies, Belgium

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

$43.3M raised

Oct 2022

Series D

Top Investors

Bill & Melinda Gates Foundation Korea Investment Partners Farallon Capital Management Kohlberg Kravis Roberts & Co.Adjuvant Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Univercells

How much funding has Univercells raised?

Univercells has raised $43.3M in total funding. The most recent round was Series D. The last funding was announced in October 2022.

Who are Univercells's investors?

Univercells's investors include Bill & Melinda Gates Foundation, Korea Investment Partners, Farallon Capital Management, Kohlberg Kravis Roberts & Co., Adjuvant Capital.

Where is Univercells headquartered?

Univercells is headquartered in Gosselies, Belgium.

What does Univercells do?

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

What stage is Univercells at?

Univercells is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 17, 2022.

MLA

"Univercells — Funding & Investors." VCBacked, October 17, 2022, https://www.vcbacked.co/company/univercells. Accessed July 11, 2026.

APA

VCBacked. (2022). Univercells — Funding & Investors. Retrieved July 11, 2026, from https://www.vcbacked.co/company/univercells

Wikipedia (cite web)

{{cite web |title=Univercells — Funding & Investors |url=https://www.vcbacked.co/company/univercells |website=VCBacked |access-date=July 11, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 17, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K